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Abstract: The production of secondary metabolites by a new isolate of the purple sulfur bacterium
Allochromatium vinosum, which had shown antibiotic activities during a preliminary study, revealed
the production of several metabolites. Growth conditions suitable for the production of one of
the compounds shown in the metabolite profile were established and compound 1 was purified.
The molecular formula of compound 1 (C20H28O2) was determined by high resolution mass spectra,
and its chemical structure by means of spectroscopic methods. The evaluation of these data revealed
that the structure of the compound was identical to dehydroabietic acid, a compound known to be
characteristically produced by conifer trees, but so far not known from bacteria, except cyanobacteria.
The purified substance showed weak antibiotic activities against Bacillus subtilis and Staphylococcus
lentus with IC50 values of 70.5 µM (±2.9) and 57.0 µM (±3.3), respectively.
Keywords: anoxygenic phototrophic bacteria (APB); Allochromatium vinosum; secondary metabolites;
dehydroabietic acid; antibiotic
1. Introduction
In contrast to the oxygenic cyanobacteria, little knowledge exists on secondary metabolites of the
anoxygenic phototrophic bacteria. From a total of 200 isolates, only two identified as Marichromatium
purpuratum showed antibiotic activity with a broad antimicrobial spectrum [1]. The activity was
associated with the chromatophore fraction of the cells. Production of antibiotic substances has also
been demonstrated in aerobic marine phototrophic bacteria affiliated with the genus Roseobacter and the
compound produced during the whole growth cycle was identified as the new substance tropodithietic
acid [2]. In addition, genes of PKS and NRPS biosynthetic pathways were identified in several isolates
belonging to the Roseobacter clade [3].
In another study, three cytokinins were found in the cells of Rhodospirillum rubrum, one of these
identified as zeatinriboside [4]. In Rhodobacter sphaeroides, two indole terpenoids were identified, both
of which exhibited phytohormone activity and were regarded as results of biotransformation reactions
of supplied substrates: rhodethrin was produced after growth with L-tryptophan [5] and rhodestrin
was produced when grown on anthranilate [6]. In the same strain, a third indole ester was identified
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as an indole carboxylate esterified with a terpenoid alcohol after growth with 2-aminobenzoate of the
same strain [7].
Though diterpenes have been extensively studied in plants and fungi, increasing evidence
is accumulating that terpene biosynthesis is widespread also in bacteria [8–10]. In anoxygenic
phototrophic bacteria, evidence exists for their presence in different phylogenetic branches.
In Chloroflexus aurantiacus, e.g., verrucosan-2ß-ol [11] and in Rhodospirillum rubrum isoagathenediol [12]
were identified.
The diterpenoids dehydroabietic and abietic acids are commonly associated with plants and fungi
and are quite characteristically produced by conifer trees. They also have been identified recently in
a wide range of cyanobacteria [13]. These authors suggested biosynthesis via the methylerythrol
pathway (the only known terpene biosynthesis pathway in cyanobacteria) using pyruvate and
glyceraldehyde-3-phosphate as substrates. They also conclude that the biosynthesis of these two
compounds in plants has cyanobacterial origin because the synthesis of abietadiene takes place in the
chloroplasts of the plants.
In the present study, initiated to identify secondary metabolites of phototrophic purple bacteria,
which are Gammaproteobacteria, we have for the first time demonstrated the production of
dehydroabietic acid by the purple sulfur bacterium Allochromatium vinosum MT86.
2. Results
2.1. Phylogenetic Analysis and Identification of the Isolate
Strain MT86 was isolated from a marine sandy rock pool near Trivendrum on the southwest coast
of India and classified according to phenotypic properties and 16S rRNA gene sequence analysis as a
strain of the species Allochromatium vinosum. Sequence identity with the type strain of Allochromatium
vinosum DSM 180T was 100% (Genbank accession number FM178268). It was found that crude cultures
of strain MT86 revealed antibiotic activities and therefore it was selected for a more detailed study on
the secondary metabolite production.
2.2. Metabolite Profiles, Fractionation of Extracts and Purification of Compound 1
Metabolite profiles of culture extracts were compared after growth in Pfennigs medium using
analytical HPLC-DAD/MS chromatography with two types of columns. Among a number of variations
of the Pfennigs medium, a medium containing MgCl2 and supplemented with thiosulfate and acetate
provided the best conditions for growth and metabolite production of Allochromatium vinosum strain
MT86. The largest number of metabolites was produced under these conditions. A typical HPLC
chromatogram of an extract from a batch culture grown in this medium is shown in Figure 1.Mar. Drugs 2018, 16, x 3 of 9 
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Figure 1. Semi-preparative HPLC (polar column) of an extract obtained from 45 L culture broth of
T86 with 0.7% salt. Peak F13 corresponds to compound 1.
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The compound with the peak identification number F13 and later identified as dehydroabietic
acid was produced by Allochromatium vinosum MT86 under various growth conditions. It was excreted
by the cells and detected in the culture supernatant, but not within the cells. By comparing various
cultivation conditions, the best conditions for the production of dehydroabietic acid were determined
to be in Pfennigs medium supplemented with 0.7% NaCl after incubation for 10 days in light.
Extracts of the culture supernatant were fractionated by semi-preparative HPLC by using the
UV absorption to fractionate the peaks manually. The polar column (4 µL Polar-RP 80A, 250 mm
× 21.20 mm, Phenomenex Synergi) was better suited for fractionation compared to the C18 column.
2.3. Purification of Compound 1
Compound 1 was prepared and purified from several culture batches with a total volume of 50 L and
the purified fractions were combined. Purity of the substance from different batches was confirmed by
HPLC-DAD/MS analysis and 1H-NMR. From these data, the identity of fractions from different batches
was also confirmed. The purified fractions from different culture batches were pooled and purified.
The final purification of the pooled batches was made on a Sephadex LH20 column with methanol as
solvent. The pure substance (a final yield of 2.5 mg pure substance was obtained from culture supernatant
of approximately 50 L) was used for chemical structure analysis (1H-NMR in CD3OD).
Purity check of compound 1 was made by separation by HPLC (column: Nucleodur C18, 5 um,
100 A, 250 mm × 3 mm; solvent: acetonitrile/water gradient with 0.1% TFA). Detection was at 220 nm
and by ELSD. Compound 1 has a retention time of 22.27 min and appears to be rather lipophilic.
The UV spectrum has a maximum at 215 nm and weak bands at 267/273 nm, which could derive from
a phenyl ring.
2.4. Structure Analysis of Compound 1
From the 12 apparent absorption peaks of the IR spectrum, one significant absorption peak at
1698 cm−1 was identified as a carboxyl group (CO-stretching vibration). From the highly resolved
molecular mass of 299.2017 (M − H)− and 323.1982 (M + Na)+, the molecular formula C20H28O2 could
be deduced. According to the molecular formula, seven double bond equivalents were predicted
for the structure, four of which relate to an aromatic ring, one to a carboxyl group and two to the
aliphatic part of the molecule, which points to two aliphatic rings being attached to the aromatic
ring. The 1H NMR spectra gave information on three aromatic-H (δ7.13, δ6.95, and δ6.85), which
indicate a trisubstituted benzene ring (Table 1). In addition, 24 aliphatic-H were present, of which 12
belong to four CH3-groups (δ1.19, δ 1.22), and in addition two further aliphatic-H (δ2.85 and δ2.79)
and further ten aliphatic protons (δ2.26–1.41) were indicated. The H from the carboxyl group was not
visible. From COSY and HMBC spectra, the position of the isopropyl group at the aromatic ring was
delineated. The 13C-NMR in connection with the DEPT and HSQC measurements gave information on
the 20 C atoms (Table 1). One acidic carbonyl carbon (δ184.52), six aromatic carbons signals (δ147–124)
(according to a phenyl group), and 13 aliphatic carbon signals (δ46.82–16.61) represented by four CH3,
five CH2, two CH and two Cq (δ37.12 and δ 47.82) were detected. The oxygen is exclusively bound
within a carboxyl group (δ184.52). According to the NMR analysis, the structure of F13, as shown
in Figure 2, corresponds to dehydroabietic acid [13–16]. The connectivity of the carbon skeleton and
the attached H-atoms and groups was determined by 1H/1H-COSY and HBMC spectra (Figure 3).
The given absolute configuration is confirmed by the optical rotation [αD]20 = + 42 (c = 0.1 in methanol)
and the CD maxima at 220 (ε 10,988) and 209 nm (ε 16.200).
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Table 1. 13C NMR and 1H-NMR spectroscopic data of compound 1 in CD2Cl2 (δC und δH in ppm).
No. of C δC C-Atom H-Atom δH Position
1 184.52 COOH 1 C-18
2 147.23 C C-9
3 145.89 C C-13
4 134.99 C C-8
5 127.03 CH 1 6.85 C-14
6 124.28 CH 1 7.13 C-11
7 123.99 CH 1 6.95 C-12
8 47.82 C C-4
9 45.22 CH 1 2.15 C-5
10 38.40 CH2 2 2.26/1.41 C-1
11 37.20 CH2 2 1.74/1.62 C-3
12 37.12 C C-10
13 33.87 CH 1 2.79 C-15
14 30.39 CH2 2 2.85 C-7
15 25.23 CH3 3 1.19 C-20
16 24.16 CH3 3 1.20 C-16
17 24.16 CH3 3 1.20 C-17
18 22.05 CH2 2 1.80/1.50 C-6
19 18.97 CH2 2 1.74/1.66 C-2
20 16.61 CH3 3 1.22 C-19
Total 20 C 28 H
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2.5. Biological Activities
Compound 1 exhibited antibiotic activities only against the Gram-positive test strains.
Escherichia coli and Candida glabrata were not inhibited. IC50 values against Bacillus subtilis and
Staphylococcus lentus were 70.5 µM (±2.9) and 57.0 µM (±3.3), respectively. These values compare to
IC50 values of chloramphenicol, of 1.45 µM (±0.13) and 2.13 µM (±0.11), respectively.
2.6. Genetic Approval of Secondary etabolite Biosynthetic Pathways
PCR a plification for genes of established biosynthetic path ays for secondary etabolite
production ere perfor ed using established pri er syste s for polyketides (pks I and pks II)
non-riboso al peptides (nrps), and phenazines (phzE fragments). None of these biosynthetic pathways
could be detected by these PCR amplifications. However, searching with antiSMASH [17] in the
genome of Allochromatium vinosu DSM 180T demonstrated the presence of terpene biosynthesis
gene clusters. In the established genome sequence of Allochromatium vinosum MT86, all steps of the
biosynthesis of geranyl-PP and geranyl-geranyl-PP were present (data not shown), although indication
for the reactions to diterpenoid biosynthesis, in particular abietic acid, could not be demonstrated.
This failure could, however, be based on the lack of sufficient information in the genomic databases in
regard to the diterpenoid biosynthesis pathway and may not exclude the presence of these biosynthetic
steps. Therefore, proof for the biosynthesis of copalyl-PP and abietic acid by Ach. vinosum has to await
future investigations.
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This is the first report of dehydroabietic acid from a proteobacterium, an anoxygenic phototrophic
bacterium, produced under proper growth conditions and excreted into the culture medium.
Although basic routes of the terpene biosynthetic pathway are common to all anoxygenic phototrophic
bacteria, abietic acid and dehydroabietic acid have so far not been identified. Geranylgeranyl-PP
is a central intermediate in the basic biosynthetic routes for carotenoid biosynthesis common to all
phototrophic purple bacteria and also established in the genome of Ach. vinosum MT86. It is a precursor
of phytoene and a diverse array of different carotenoids produced in these bacteria [18] as well as for
the phytoyl moiety attached to the bacteriochlorophyll molecules of most phototrophic purple bacteria.
In addition, hopanoid triterpenes produced by a number of anoxygenic phototrophic purple bacteria
have geranylgeranyl pyrophosphate as precursor [19,20].
Dehydroabietic acid exhibits some interesting bioactivities including moderate antibiotic activities
against Bacillus subtilis and Staphylococcus lentus, as found in the present study and also cytotoxic
activities as demonstrated for a derivative of dehydroabietic acid recently [21]. Our study showed that
the exploration of anoxygenic phototrophic purple bacteria for the production of bioactive compounds
should be taken into consideration for biodiscovery.
4. Materials and Methods
4.1. Isolation and Identification of Strain MT86
Strain MT86 was isolated from a sandy rock pool near to Trivendrum (Kerals, southwest coast of
India) and pure cultures were obtained according to standard procedures [22]. Identification as
a strain of Allochromatium vinosum was achieved using 16S rRNA gene sequences according to
Gärtner et al. [23]. The 16S rRNA gene sequence (1353 nucleotides) was deposited in GenBank with
the accession number MH678637.
4.2. Cultivation and Preparation of Cell Extracts
The strain was grown in Pfennigs medium amended with 1% thiosulfate and 1% acetate-solution
(NH4-acetate/Mg-acetate, 2.5 g each/100 mL) using 1 L screw capped bottles. Well grown cultures
were centrifuged to separate cell biomass and liquid supernatant. The supernatant was extracted with
ethyl acetate (1:1 by volume); phase separation was allowed in a separatory funnel and the upper ethyl
acetate phase was filtered (Whatman 595 12 ) to remove solid impurities and water. The extract was
concentrated to dryness in a rotary evaporator and resolved in a small volume of methanol. For control
experiments, uninoculated medium was extracted directly by ethyl acetate without centrifugation
steps and the extract treated the same way. All extracts were finally dissolved in methanol and filtered
through 0.2 µm PTFE syringe filter before applying to analytical and semi-preparative HPLC.
4.3. Analytical HPLC-DAD/MS
The crude extract was re-dissolved in methanol to a concentration of 1.0 mg/mL and subjected
to HPLC-DAD/MS using a VWR Hitachi Elite LaChrom system Elite (VWR, Darmstadt, Germany)
with an L-2450 diode array detector, an L-2130 pump, and an L-2200 autosampler. This HPLC system
was coupled to an ESI-ion trap detector with positive ionization (Esquire 4000, Bruker Daltonics,
Faellanden Switzerland) for mass detection. A Onyx Monolithic reversed phase C18 column (100 mm
× 3.00 mm; Phenomenex, Torrance, CA, USA) with solvent A (0.1% formic acid in 100% acetonitrile)
and solvent B (0.1% formic acid in 100% Milli-Q water) was applied. The gradient parameters were:
0 min 95% A, 4 min 40% A, 6 min 0% A; flow: 2 mL/min).
4.4. Semi-Preparative HPLC
Semi-preparative HPLC was performed using a VWR Hitachi Elite LaChrom Elite HPLC
system (VWR, Darmstadt, Germany). This system consisted of a C18 column (Phenomenex Gemini,
110 A AXIA, 100 mm × 50.00 mm) and a polar column (Phenomenex Synergi, 4 µL Polar-RP 80A,
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250 mm × 21.20 mm) (Phenomenex, Torrance, CA, USA), an L-2200 autosampler (VWR, Darmstadt,
Germany), a Foxy Jr. fraction collector (Teledyne Isco, Lincoln, NE, USA), an L-7150 pump, and an
L-2450 diode array detector (VWR, Darmstadt, Germany). Solvents A and B were used with the
following gradient: start 5 mL/min with 90% solvent A, after 0.5 min 10 mL/min 80% solvent A, after
26 min 15 mL/min 100% solvent A.
4.5. NMR Analysis
1H NMR, 13C NMR spectra and 2D spectra were recorded on an Inova 600 (600 and 125 MHz,
respectively) with tetramethylsilane (TMS) as the internal standard and methanol-d(4) (MeOD) and
CD2Cl2, respectively, as solvents.
4.6. ESI-MS
Measurements of high-resolution mass spectra were performed on a Bruker-Apex III-Q mass
spectrometer (field strength 7 Tesla) (Bruker Daltonics, Faellanden, Switzerland) with positive and
negative ion mode.
4.7. Antimicrobial Activity of Compound 1
The following test organisms were used: Bacillus subtilis DSM 347 and Staphylococcus lentus
DSM 6672 as representatives of Gram-positive bacteria; Escherichia coli DSM 498 as a Gram-negative
bacterium; and the yeast Candida glabrata DSM 6425. All test organisms were obtained from the
German Culture Collection (DSMZ, Braunschweig, Germany). The assays were performed according
to Schneemann et al. [24]. Chloramphenicol (10 µM) and nystatin (10 µM) were used as positive control
for the bacteria and the yeast, respectively.
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